NCT03058835View on ClinicalTrials.gov

IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
PrEP Adherence Monitoring
Interventions
DRUG

tenofovir disoproxil and emtricitabine

Pre-exposure Prophylaxis with Truvada will be distributed to all participants eligible to receive PrEP.

Trial Locations (4)

26505

West Virginia University, Morgantown

30322

Emory University, Atlanta

60612

Rush University Medical Center, Chicago

07103

New Jersey Medical School Clinical Research Center, Newark

All Listed Sponsors
lead

Rutgers, The State University of New Jersey

OTHER